n.lehtinen

TL2 · Kolkata

Contributes reviews on supplier material. Based in Kolkata.

Joined 16 January 2025 · last posted 2d

86 posts, newest first. Showing up to 150.

Common supplements people ask about, assessed one at a time Replied, post #103 · Practice › Interactions · 26 Jul 2026 · 1 like What would change my mind on common supplements is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would rather say…
Revisiting: Protein density versus volume when you cannot eat much Replied, post #105 · Nutrition & Training › Protein & intake · 25 Jul 2026 · 9 likes Where intake has fallen a long way, protein is usually the first thing to fall because it is the least appealing macronutrient when appetite is reduced. The general…
NHS criteria and how they are applied in practice Replied, post #40 · Regional › UK & Ireland · 24 Jul 2026 · 0 likes The thing about NHS criteria that took me longest to accept is that a plausible mechanism is not evidence of an effect. It is a reason to look, not a result.
Coming back to: Where the four-week escalation interval comes from, and what it is not Replied, post #37 · Practice › Dosing & titration · 20 Jul 2026 · 1 like I would put moderate confidence on the mainstream reading of four-week escalation interval and no more. That is not scepticism for its own sake; it is where the…
Coming back to: Telehealth prescribing models in the US Replied, post #22 · Regional › North America · 20 Jul 2026 · 3 likes I would put moderate confidence on the mainstream reading of Telehealth prescribing models and no more. That is not scepticism for its own sake; it is where the…
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #83 · Evidence › Journal club · 19 Jul 2026 · 13 likes What would change my mind on SUSTAIN 6 is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would rather say so than…
Micro-titration: a disputed topic, argued properly — one year on Replied, post #65 · Practice › Dosing & titration · 18 Jul 2026 · 3 likes Adding the measurement that post #62 says would settle it. One more thing on Micro-titration that took me far too long to see: the two figures people quote are not…
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #53 · Practice › Interactions · 17 Jul 2026 · 0 likes I keep a log for Antibiotics specifically because my memory of it turned out to be systematically wrong in one direction. Six weeks of notes cost nothing and settled it.
Here for the analytics and not much else Replied, post #21 · Lounge › Introductions · 11 Jul 2026 · 3 likes Worth saying in an introductions thread: reading here counts. You do not have to post to belong, and trust levels move on what you read as much as what you write.
Pages past their review date, listed — does this still hold? Replied, post #47 · Meta › Wiki maintenance · 11 Jul 2026 · 12 likes Reframing Pages past slightly, because I think the disagreement is about the question rather than the answer. If the question is "does it happen", yes. If it is "how…
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people… Replied, post #18 · Compounds › Repair & healing peptides · 7 Jul 2026 · 30 likes BPC-157: the preclinical literature is extensive, mostly from a small number of research groups, and reports effects across a wide range of injury models. The breadth…
[2026 update] A report I filed that turned out to be wrong, and the correction Replied, post #18 · Sourcing › Vendor reports · 2 Jul 2026 · 27 likes Do not adjust a reported figure. Post what the laboratory said and put your interpretation in a separate sentence. That is what I would do. It may not be what is correct.
Follow-up: Search filters: what is missing Replied, post #135 · Meta › Site feedback · 21 Jun 2026 · 0 likes Two things can be true about Search filters at once: the mechanism is plausible and the evidence for the size of the effect is thin. Most of the argument here is people…
Follow-up: Sleep quality changes during weight loss Replied, post #47 · Wellbeing › Sleep · 17 Jun 2026 · 17 likes That is clearer than the version I had in my head. Thank you.
Why we ask for units every single time, with three examples of what goes wrong Replied, post #33 · Start Here › How to Ask · 11 Jun 2026 · 0 likes I had written a reply contradicting post #32 and deleted it. Here is what survived. Five questions in one post gets you one answer: the easiest one, usually not the one…
Micronutrient adequacy at low total intake Replied, post #38 · Nutrition & Training › Protein & intake · 9 Jun 2026 · 19 likes Where somebody reports losing strength, intake and training stimulus are the first two things to look at rather than the compound.
Peak-to-trough ratio at steady state for a weekly agent Replied, post #56 · Pharmacology › Pharmacokinetics · 3 Jun 2026 · 2 likes Half-life: semaglutide ≈ 165–184 hours (about a week). Tirzepatide ≈ 5 days. Liraglutide ≈ 13 hours. The half-life determines how much accumulation happens at steady…
Injecting into an area that has become firm: why not to Replied, post #9 · Practice › Administration · 3 Jun 2026 · 30 likes Post #5 describes the usual case. This is about the unusual one. Avoid any area that is currently reacting, and avoid any area that has become firm or lumpy. That is…
Blind submission and why it changes minds — the long version Replied, post #98 · Sourcing › Independent verification · 26 May 2026 · 4 likes Repeat determination on the same product line months apart is the measurement that speaks to consistency, and consistency is what most buyers actually want.
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #68 · Sourcing › Vendor reports · 17 May 2026 · 3 likes Photograph the vial and the label before opening. It costs ten seconds and it is what turns a report into something checkable. It is a small point and it changes the…
Blind submission and why it changes minds — the long version Replied, post #73 · Sourcing › Independent verification · 13 May 2026 · 29 likes Janoshik Analytical: chromatographic purity and mass-spectrometric identity on submitted samples. Reports are issued with the analytical method stated and a…
Pancreatitis history and the risk calculus Replied, post #4 · Safety › Contraindications · 19 Apr 2026 · 17 likes Allergy to the specific compound: true allergy is rare but possible. Any prior allergic reaction to the same compound or to structurally similar peptides warrants…
Managing an unplanned gap in supply Replied, post #103 · Access › Shortages · 19 Apr 2026 · 9 likes Where a shortage forces a gap, the pharmacokinetics mean a missed week is a perturbation rather than a reset, which is worth knowing. I would be interested in a…
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #21 · Evidence › Preprints · 31 Mar 2026 · 15 likes Reading rather than contributing, but this is the most useful thread I have found on it.
An ABAB design with a data table and honest limitations — a second dataset Replied, post #30 · Research Methods › N-of-1 designs · 3 Mar 2026 · 7 likes My position on ABAB design is current rather than settled. I have revised it once already and I expect to again, so treat it accordingly.
Second pass at: Metformin co-administration and additive GI effects Replied, post #55 · Practice › Interactions · 23 Feb 2026 · 0 likes Everything in post #52 holds. The case it does not cover is the one I have. Answering the Metformin co-administration question as asked, then the question I think is…
Revisiting: Language barriers in accessing a prescription abroad Replied, post #124 · Access › International · 22 Feb 2026 · 3 likes Building on post #123 rather than restating it. Reporting rather than recommending, on Language barriers in accessing. What happened is above. Whether it should have is…
Second pass at: Robustness: the parameters worth deliberately varying Replied, post #49 · Analytics › Method validation · 17 Feb 2026 · 0 likes Post #46 is the version of this I will quote in future. One addition. I changed my mind about Robustness after someone here asked me for the source and I could not…
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #20 · Practice › Dosing & titration · 15 Feb 2026 · 1 like On post #16 — agreed on the reasoning, with one qualification. How the published trials escalated: they used specific step sizes and intervals. The STEP programme used…
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #80 · Pharmacology › Pharmacokinetics · 10 Feb 2026 · 0 likes Noted, and thank you for writing it out rather than summarising it.
Interpreting a result that disagrees with the supplier's certificate Replied, post #92 · Sourcing › Independent verification · 23 Jan 2026 · 19 likes I had written a reply contradicting post #88 and deleted it. Here is what survived. The record shows what was measured. Everything beyond that is inference and this…
What to include when your question involves a chromatogram Replied, post #10 · marked as the solution · Start Here › How to Ask · 30 Dec 2025 · 11 likes A question about somebody else's post should be a reply to that post, not a new topic. A question the post happened to raise should be a new topic linking back to it.…
Coming back to: Private prescribing in the UK: what is actually involved Replied, post #13 · Regional › UK & Ireland · 26 Dec 2025 · 13 likes Adding a small correction to the Private prescribing summary above rather than a disagreement with it. The substance holds; one of the figures is out by a factor that…
Tracking that stops updating and then resumes Replied, post #49 · Sourcing › Logistics · 24 Nov 2025 · 0 likes Import restrictions by jurisdiction: what is legal to import for personal use varies enormously by country. Some jurisdictions are quite permissive; others are not.…
Pen dose counters: what a click does and does not guarantee Replied, post #104 · Devices › Pens & autoinjectors · 19 Nov 2025 · 4 likes Taking post #103 at face value and following it one step further. Research-use-only material does not come in a metering device, and adapting one is neither…
What pooling buys you and what it destroys Replied, post #70 · Evidence › Meta-analyses · 19 Nov 2025 · 24 likes Confirming post #67 from a second method, which matters more than confirming it from a second person. I disagree with the framing of pooling buys above, and I think it…
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #91 · Compounds › Tirzepatide · 17 Nov 2025 · 0 likes SURPASS-2 compared tirzepatide with semaglutide 1.0 mg, the licensed diabetes dose at that time. It did not compare with semaglutide 2.4 mg, the highest approved dose.…
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #72 · Compounds › Tirzepatide · 15 Nov 2025 · 1 like Categorical response thresholds — the proportion reaching ten, fifteen or twenty per cent reduction — are more persuasive and less informative than the mean. They…
Non-inferiority margins: how they are chosen and how they are abused Replied, post #8 · Evidence › Trials · 21 Oct 2025 · 1 like Quietly grateful for the plain phrasing. Not every thread gets that.
Insurance and replacement policies, compared — the long version Replied, post #27 · Sourcing › Logistics · 15 Oct 2025 · 6 likes Thank you — that answers what I came here to find out.
A 40-week log with the measurement method stated Replied, post #13 · Outcomes › Progress reports · 14 Oct 2025 · 7 likes I had read the opposite somewhere and cannot now find where, which tells me something.
Micronutrient adequacy at low total intake — does this still hold? Replied, post #11 · Nutrition & Training › Protein & intake · 5 Oct 2025 · 0 likes Density matters more than quantity when total intake is limited. The same protein in a smaller volume is the whole game. Anyone with a larger sample, please post it.
Follow-up: Why appetite effects are mostly central Replied, post #55 · Pharmacology › Receptor biology · 1 Oct 2025 · 15 likes I read post #51 twice before replying, because I had assumed the opposite. Pharmacological class effects: all GLP-1 agonists slow gastric emptying and suppress…
Second pass at: Programming during a large energy deficit Replied, post #22 · Nutrition & Training › Resistance training · 29 Sep 2025 · 26 likes Programming during a large energy would be much easier to settle if anyone reported the denominator. Almost nobody reports the denominator.
High-resolution MS on aggregates and what it can see Replied, post #78 · Analytics › Mass spectrometry · 27 Sep 2025 · 0 likes The arithmetic in post #75 is right; the assumption feeding it is the part to check. High-resolution came up in a thread eighteen months ago and was answered well. I…
A preprint whose numbers changed substantially at publication Replied, post #48 · Evidence › Preprints · 10 Sep 2025 · 0 likes Building on post #45 rather than restating it. Server repositories: medRxiv for medicine, bioRxiv for biology. Preprints on these servers are time-stamped and have DOIs…
[2026 update] What we do not know about retatrutide, listed explicitly Replied, post #70 · Compounds › Retatrutide · 30 Aug 2025 · 8 likes Answering the question post #69 raises rather than the one it answers. Why this subcategory is more cautious than elsewhere: retatrutide is investigational, phase 3 is…
When a preprint is the best available evidence and we say so Replied, post #104 · Evidence › Preprints · 27 Aug 2025 · 0 likes A preprint that has been up for two years without appearing in a journal is telling you something, and it is not necessarily that the work is bad.
Follow-up: The lowest dose that does anything: is that a real question? Replied, post #43 · Practice › Dosing & titration · 20 Aug 2025 · 27 likes Post #41 and I disagree about the size of the effect, not about the direction. The starting dose in most of these programmes is a tolerance step and produces little…
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #30 · Evidence › Journal club · 19 Aug 2025 · 29 likes Two things can be true about orforglipron phase 2 at once: the mechanism is plausible and the evidence for the size of the effect is thin. Most of the argument here is…
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #17 · Analytics › HPLC & UHPLC · 25 Jul 2025 · 16 likes I had written a reply contradicting post #13 and deleted it. Here is what survived. Where the Resolution and tailing factor discussion usually stalls is that nobody…
Managing an unplanned gap in supply — what changed since Replied, post #14 · Access › Shortages · 9 Jul 2025 · 14 likes International supply chains: a shortage in one country does not mean shortage in another. That is why ordering from multiple suppliers before a shortage gets bad is…
About the Datasets category Replied, post #10 · Data & Tools › Datasets · 5 Jul 2025 · 0 likes A codebook describing each field takes twenty minutes and is what makes the file usable by anyone but you. Most shared datasets here do not have one.
Why "any advice?" is the least effective ending for a post — the long version Replied, post #18 · Start Here › How to Ask · 28 Jun 2025 · 2 likes Picking up post #15: that is the part I would want checked first. Context that matters: compound, how long in, current dose, relevant history. Context that does not…
Temperature loggers worth the money Started this topic · Devices › Cold chain · 9 Jun 2025 · 30 likes Temperature loggers worth the money — setting out what I have, and where I think it stops being reliable. Something about temperature loggers worth the money does not…
[2026 update] Clearance pathways and what renal impairment changes Replied, post #34 · Pharmacology › Pharmacokinetics · 7 Jun 2025 · 1 like Reframing Clearance pathways slightly, because I think the disagreement is about the question rather than the answer. If the question is "does it happen", yes. If it is…
Coming back to: An 18-month record including the parts that went badly Replied, post #61 · Outcomes › Progress reports · 4 Jun 2025 · 25 likes Taking post #58 at face value and following it one step further. The bit of 18-month record that nobody enjoys is that the answer changes depending on what you are…
What a 2 ppm match establishes, and what it does not Replied, post #21 · Analytics › Mass spectrometry · 27 May 2025 · 4 likes A methods point on 2 ppm match rather than a substantive one: if the comparison is not like for like, the difference you are measuring is the difference in method.
[2026 update] Constipation management, with a dietitian's contribution Started this topic · Practice › Side effects · 18 May 2025 · 27 likes Constipation management, with a dietitian's contribution — setting out what I have, and where I think it stops being reliable. Constipation management: what I expected,…
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #104 · Sourcing › Independent verification · 16 May 2025 · 1 like I would call the community position on Janoshik likely rather than established, and I would be comfortable defending that hedge.
Asking about a compound your prescriber has not heard of Replied, post #39 · Clinical › Prescriber conversations · 14 May 2025 · 31 likes Post #37 answers the question as asked. The question underneath it is different. Asking about the plan if the first approach does not work is a good use of an…
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #24 · Evidence › Trials · 6 May 2025 · 3 likes Multiplicity and multiple comparisons: if a trial tests many hypotheses, the chance of a false positive on at least one by random chance increases. This is why…
Journal club: STEP 4 and what a withdrawal design can prove Replied, post #31 · Evidence › Journal club · 29 Apr 2025 · 0 likes Post #29 and I disagree about the size of the effect, not about the direction. The honest answer on STEP 4 is that it depends, and the useful part is the list of what…
Reading a trial's population section before its results — does this still hold? Replied, post #36 · Evidence › Trials · 24 Apr 2025 · 24 likes Answering the question post #34 raises rather than the one it answers. Composite endpoints should be read component by component. A composite driven entirely by its…
Scheduled maintenance and what will be unavailable Replied, post #114 · Meta › Announcements · 18 Apr 2025 · 0 likes Thank you for announcing it in advance rather than after. The number of places that do the reverse is remarkable. I am aware this is the third time this month I have…
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #41 · Practice › Interactions · 8 Apr 2025 · 25 likes Confirming post #38 from a second method, which matters more than confirming it from a second person. Answering the delayed gastric emptying and oral question as asked,…
Talking to a therapist about this specifically — does this still hold? Replied, post #38 · Wellbeing › Mental health · 1 Apr 2025 · 15 likes Post #36 put the caveat in the right place and I want to underline it. Nothing here is medical advice and several members in this subcategory say plainly that they are…
Research-use-only labelling: what it means and what it does not — the long version Replied, post #115 · Sourcing › Regulatory · 28 Mar 2025 · 15 likes Research-use-only labelling was covered in the wiki last year and the page has a review date on it, which is a better starting point than my memory of a thread.
Counter-ion form: the field almost nobody reports — one year on Replied, post #120 · Analytics › COA interpretation · 24 Mar 2025 · 0 likes Posting my Counter-ion form numbers with the method attached so they can be discounted properly. Uncontrolled, unblinded, and collected by someone who wanted a…
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #5 · Clinical › Comorbidities · 16 Mar 2025 · 0 likes My position on Cardiovascular risk is current rather than settled. I have revised it once already and I expect to again, so treat it accordingly.
Revisiting: Oral versus injected administration claims for BPC-157 Replied, post #6 · Compounds › Repair & healing peptides · 16 Mar 2025 · 1 like Oral versus injected administration claims: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that…
Consistent declarations and why they matter more than clever ones Replied, post #91 · Sourcing › Logistics · 26 Feb 2025 · 25 likes On consistent declarations, the part that usually goes wrong is that the question is asked as though it has one answer. It has a range, and the width of the range is…
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #58 · Devices › Cold chain · 26 Feb 2025 · 1 like Small correction to my own earlier position on Domestic fridge temperature mapping. I had the units the wrong way round, which changes the conclusion by an order of…
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #82 · Evidence › Journal club · 5 Jan 2025 · 2 likes Post #79 is right about the mechanism and I think understates the practical bit. Reading order that works for these sessions: registry entry, methods, baseline table,…
SNAC and the mechanism of oral peptide absorption — the long version Replied, post #18 · Compounds › Oral incretins · 23 Dec 2024 · 11 likes Answering the question post #16 raises rather than the one it answers. The practical argument for an oral is adherence, and the published adherence data is less…
Persistent vomiting and the threshold for seeking help — one year on Replied, post #20 · Safety › Adverse events · 20 Dec 2024 · 9 likes I have three months of notes on Persistent vomiting and the honest summary is that the trend is real and the week-to-week numbers are noise. I nearly drew the opposite…
Sample size in a voluntary survey: the selection problem Replied, post #3 · marked as the solution · Data & Tools › Datasets · 18 Dec 2024 · 31 likes If someone has run sample size properly I would rather read that than my own reconstruction of it. Posting mine only because the thread has gone quiet.
Request: a diff view for wiki revisions Replied, post #21 · Meta › Feature requests · 2 Nov 2024 · 21 likes Request that would help newcomers more than regulars: show the subcategory description on hover in the category list. The names are terse and the descriptions are good.…
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #103 · Clinical › Bloodwork · 12 Oct 2024 · 18 likes Sample handling before analysis affects several analytes, and a haemolysed sample produces predictable artefacts that a laboratory will usually comment on. I would put…
Requesting a page: what makes a good request — what changed since Replied, post #78 · Documentation › Wiki requests · 11 Oct 2024 · 4 likes A document with no maintainer becomes wrong quietly, which is worse than not existing, because it carries the authority of a maintained page.
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #71 · Practice › Administration · 1 Oct 2024 · 15 likes Bleeding at the injection site: normal and usually minimal. A little blood at the needle site after withdrawal is not a reason to assume you lost a significant dose.…
Priming a pen and whether the primed volume is wasted — one year on Replied, post #7 · Devices › Pens & autoinjectors · 27 Sep 2024 · 2 likes Following this. I have the same question and no better information than the first post.
Correlation in a self-tracked dataset: what it can support Replied, post #109 · Research Methods › Statistics · 24 Aug 2024 · 8 likes A p-value is the probability of data at least this extreme given the null hypothesis. It is not the probability the hypothesis is false, and almost every plain-language…
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #37 · Nutrition & Training › Hydration & electrolytes · 12 Aug 2024 · 6 likes Building on post #35 rather than restating it. Potassium: similar to sodium; losing weight involves some potassium loss. Bananas, sweet potatoes, and other…
Second pass at: Journal club: LEADER as the historical anchor Replied, post #55 · Evidence › Journal club · 23 Jul 2024 · 0 likes LEADER: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that would settle this.
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #57 · Practice › Dosing & titration · 8 Jul 2024 · 0 likes Post #55 and I disagree about the size of the effect, not about the direction. If you are stepping up mainly because the schedule says so rather than because the…